NasdaqGS:MMEDMedical Equipment
MiniMed Group (MMED) Q3 Loss Undercuts Bullish Profitability Narrative Despite Revenue Base
MiniMed Group (NasdaqGS:MMED) has released its Q3 2026 results, reporting quarterly revenue of US$737.5 million and a net income loss of US$14.5 million, while the share price trades around US$14.44. Over the past few reported periods, the company’s quarterly revenue has moved from US$652 million in early 2025 to US$737.5 million in early 2026, with net income losses narrowing from US$15.5 million to US$14.5 million. This frames a narrative centered on how efficiently that top line can be...